Anti-Apolipoprotein L 1 antibody (ab116607)

Overview

  • Product nameAnti-Apolipoprotein L 1 antibody
    See all Apolipoprotein L 1 primary antibodies
  • Description
    Goat polyclonal to Apolipoprotein L 1
  • Specificityab116607 is expected to recognize all three reported isoforms (NP_003652.2; NP_663318.1; NP_001130013.1). Reported variants represent identical protein: NP_003652.2, NP_001130012.1.
  • Tested applicationsSuitable for: WBmore details
  • Species reactivity
    Reacts with: Human
  • Immunogen

    Synthetic peptide:

    PHASASRPRVTEP

    with a Cysteine residue linker, corresponding to internal sequence amino acids 297-309 of Human Apolipoprotein L 1 (NP_003652.2; NP_663318.1; NP_001130013.1).

  • Positive control
    • Human Placenta lysate.

Properties

Associated products

Applications

Our Abpromise guarantee covers the use of ab116607 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB Use a concentration of 0.1 - 0.3 µg/ml. Detects a band of approximately 42,45 kDa (predicted molecular weight: 42,46 kDa).

Target

  • FunctionMay play a role in lipid exchange and transport throughout the body. May participate in reverse cholesterol transport from peripheral cells to the liver.
  • Tissue specificityPlasma. Found on APOA-I-containing high density lipoprotein (HDL3). Expressed in pancreas, lung, prostate, liver, placenta and spleen.
  • Involvement in diseaseDefects in APOL1 are the cause of focal segmental glomerulosclerosis type 4 (FSGS4) [MIM:612551]. It is a renal pathology defined by the presence of segmental sclerosis in glomeruli and resulting in proteinuria, reduced glomerular filtration rate and edema. Renal insufficiency often progresses to end-stage renal disease, a highly morbid state requiring either dialysis therapy or kidney transplantation.
  • Sequence similaritiesBelongs to the apolipoprotein L family.
  • Post-translational
    modifications
    Phosphorylation sites are present in the extracelllular medium.
  • Cellular localizationSecreted.
  • Information by UniProt
  • Database links
  • Alternative names
    • APO L antibody
    • Apo-L antibody
    • ApoL antibody
    • APOL I antibody
    • ApoL-I antibody
    • APOL1 antibody
    • APOL1_HUMAN antibody
    • APOLI antibody
    • Apolipoprotein L antibody
    • Apolipoprotein L I antibody
    • Apolipoprotein L-I antibody
    • Apolipoprotein L1 antibody
    • FSGS4 antibody
    see all

Anti-Apolipoprotein L 1 antibody images

  • Anti-Apolipoprotein L 1 antibody (ab116607) at 0.1 µg/ml + Human Placenta lysate at 35 µg
    Developed using the ECL technique

    Predicted band size : 42,46 kDa

References for Anti-Apolipoprotein L 1 antibody (ab116607)

ab116607 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab116607.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"